Canonical mechanism of ferroptosis
Canonical mechanism of ferroptosis. Ferroptosis is a type of regulated cell death characterized by excess iron in the LIP and the lethal accumulation of lipid peroxidation products. Fe3+ is transferred into the cell by TFR1, is converted to Fe2+ in the endosome and is then released from the endosome by DMT1. Iron-containing ferritin is degraded to produce a large amount of free iron via NCOA4-mediated ferritinophagy, resulting in ferroptosis. The Fenton reaction promotes lipid peroxidation by activating lipoxygenases. Cystine is taken up by System Xc- for the synthesis of GSH, which further enhances the anti-lipid peroxidation activity of GPX4. In addition, FSP1-CoQ10 and GCH1-BH4 are two parallel GSH-independent pathways involved in the suppression of ferroptosis
Publication
Current Progress of Ferroptosis Study in Hepatocellular Carcinoma (2024) Xinyue Zhu, et al. Int J Biol Sci. 2024;20(9). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TF | TF | ncbigene_symbol | TF | 7018 |
| Homo sapiens | Primates | TER | TER | ncbigene_synonym | TERC | 7012 |
| Homo sapiens | Primates | TER | TER | ncbigene_synonym | TECR | 9524 |
| Homo sapiens | Primates | STEAP3 | STEAP3 | ncbigene_symbol | STEAP3 | 55240 |
| Homo sapiens | Primates | PLS | PLS | ncbigene_synonym | CTSC | 1075 |
| Homo sapiens | Primates | NCOA4 | NCOA4 | ncbigene_symbol | NCOA4 | 8031 |
| Homo sapiens | Primates | DMT1 | DMT1 | ncbigene_synonym | DMRT1 | 1761 |
| Homo sapiens | Primates | DMT1 | DMT1 | ncbigene_synonym | SLC11A2 | 4891 |
| Homo sapiens | Primates | DMT1 | DMT1 | ncbigene_synonym | CHMP2B | 25978 |
| Homo sapiens | Primates | ACSL3 | ACSL3 | ncbigene_symbol | ACSL3 | 2181 |
| Homo sapiens | Primates | LIP | LIP | ncbigene_synonym | SMG1 | 23049 |
| Homo sapiens | Primates | PUFA | PUFA | ncbigene_synonym | PUM3 | 9933 |
| Homo sapiens | Primates | ACSL4 | ACSL4 | ncbigene_symbol | ACSL4 | 2182 |
| Homo sapiens | Primates | LPCAT3 | LPCAT3 | ncbigene_symbol | LPCAT3 | 10162 |
| Homo sapiens | Primates | SLC3A2 | SLC3A2 | ncbigene_symbol | SLC3A2 | 6520 |
| Homo sapiens | Primates | SLC7A11 | SLC7A11 | ncbigene_symbol | SLC7A11 | 23657 |
| Homo sapiens | Primates | SLC38A1 | SLC38A1 | ncbigene_symbol | SLC38A1 | 81539 |
| Homo sapiens | Primates | SLC1A5 | SLC1A5 | ncbigene_symbol | SLC1A5 | 6510 |
| Homo sapiens | Primates | GLS2 | GLS2 | ncbigene_symbol | GLS2 | 27165 |
| Homo sapiens | Primates | ALOX15 | ALOX15 | ncbigene_symbol | ALOX15 | 246 |
| Homo sapiens | Primates | GPX4 | GPX4 | ncbigene_symbol | GPX4 | 2879 |
| Homo sapiens | Primates | ☑Cate | CATE | ncbigene_synonym | CTSE | 1510 |
| Homo sapiens | Primates | GSR | GSR | ncbigene_symbol | GSR | 2936 |
| Homo sapiens | Primates | DHODH | DHODH | ncbigene_symbol | DHODH | 1723 |
| Homo sapiens | Primates | NADPH | NADPH | ncbigene_synonym | DECR1 | 1666 |
| Homo sapiens | Primates | FPN | FPN | ncbigene_synonym | SLC40A1 | 30061 |
| Homo sapiens | Primates | GCH1 | GCH1 | ncbigene_symbol | GCH1 | 2643 |
| Homo sapiens | Primates | FSP1 | FSP1 | ncbigene_synonym | S100A4 | 6275 |
| Homo sapiens | Primates | FSP1 | FSP1 | ncbigene_synonym | ATL1 | 51062 |
| Homo sapiens | Primates | FSP1 | FSP1 | ncbigene_synonym | AIFM2 | 84883 |
| Homo sapiens | Primates | GTP | GTP | ncbigene_synonym | MTG1 | 92170 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| MUFA | MUFA | chebi:25413 | ||
| PUFA | PUFA | chebi:76567 | ||
| Glu | Glu | 2-aminopentanedioic acid | chebi:18237 | |
| Cystine | cystine | cystine | chebi:17376 | |
| Cystine | cystine | cystine | chebi:17376 | |
| Glu | Glu | 2-aminopentanedioic acid | chebi:18237 | |
| Gln | Gln | L-glutamine residue | chebi:30011 | |
| Cysteine | cysteine | cysteine | chebi:15356 | |
| Gly | Gly | glycine | chebi:15428 | |
| Glu | Glu | 2-aminopentanedioic acid | chebi:18237 | |
| Glu | Glu | 2-aminopentanedioic acid | chebi:18237 | |
| NADP+ | NADP+ | 2'-O-phosphonoadenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:18009 | |
| GSH | GSH | L-gamma-glutamyl-L-cysteinylglycine | chebi:16856 | |
| CoQH2 | CoQH2 | a ubiquinol | chebi:17976 | |
| CoQ | CoQ | ubiquinone-10 | chebi:46245 | |
| GSSG | GSSG | (2S,2'S)-5,5'-[disulfanediylbis({(2R)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid) | chebi:17858 | |
| NADPH | NADPH | 2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57783 | |
| GTP | GTP | GTP | chebi:37565 | |
| BH4 | BH4 | 5,6,7,8-tetrahydrobiopterin | chebi:15372 | |
| CoQ | CoQ | ubiquinone-10 | chebi:46245 | |
| CoQH2 | CoQH2 | a ubiquinol | chebi:17976 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|